{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:38:53Z","timestamp":1791923933554,"version":"4.3.4"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Hypertension"],"published-print":{"date-parts":[[2019,3]]},"abstract":"<jats:p>Myocardial fibrosis is a main contributor to the development of heart failure (HF). CT-1 (cardiotrophin-1) and Gal-3 (galectin-3) are increased in HF and associated with myocardial fibrosis. The aim of this study is to analyze whether CT-1 regulates Gal-3. Proteomic analysis revealed that Gal-3 was upregulated by CT-1 in human cardiac fibroblasts in parallel with other profibrotic and proinflammatory markers. CT-1 upregulation of Gal-3 was mediated by ERK (extracellular signal-regulated kinase) 1\/2 and Stat-3 (signal transducer and activator of transcription 3) pathways. Male Wistar rats and B6CBAF1 mice treated with CT-1 (20 \u00b5g\/kg per day) presented higher cardiac Gal-3 levels and myocardial fibrosis. In CT-1\u2013treated rats, direct correlations were found between cardiac CT-1 and Gal-3 levels, as well as between Gal-3 and perivascular fibrosis. Gal-3 genetic disruption in human cardiac fibroblasts and pharmacological Gal-3 inhibition in mice prevented the profibrotic and proinflammatory effects of CT-1. Dahl salt-sensitive hypertensive rats with diastolic dysfunction showed increased cardiac CT-1 and Gal-3 expression together with cardiac fibrosis and inflammation. CT-1 and Gal-3 directly correlated with myocardial fibrosis. In HF patients, myocardial and plasma CT-1 and Gal-3 were increased and directly correlated. In addition, HF patients with high CT-1 and Gal-3 plasma levels presented an increased risk of cardiovascular death. Our data suggest that CT-1 upregulates Gal-3 which, in turn, mediates the proinflammatory and profibrotic myocardial effects of CT-1. The elevation of both molecules in HF patients identifies a subgroup of patients with a higher risk of cardiovascular mortality. The CT-1\/Gal-3 axis emerges as a candidate therapeutic target and a potential prognostic biomarker in HF.<\/jats:p>","DOI":"10.1161\/hypertensionaha.118.11874","type":"journal-article","created":{"date-parts":[[2019,1,7]],"date-time":"2019-01-07T10:59:38Z","timestamp":1546858778000},"page":"602-611","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":100,"title":["CT-1 (Cardiotrophin-1)-Gal-3 (Galectin-3) Axis in Cardiac Fibrosis and Inflammation"],"prefix":"10.1161","volume":"73","author":[{"given":"Ernesto","family":"Mart\u00ednez-Mart\u00ednez","sequence":"first","affiliation":[{"name":"From the Cardiovascular Translational Research, Navarrabiomed, Complejo Hospitalario de Navarra (CHN), Universidad P\u00fablica de Navarra (UPNA), IdiSNA, Pamplona. Spain (E.M.-M., J.I., A.F.-C., N.L.-A.)"},{"name":"INSERM UMRS 1138 Team 1, Centre de Recherche des Cordeliers, University Pierre and Marie Curie, Paris, France (E.M.M., M.B., F.J.)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Brugnolaro","sequence":"additional","affiliation":[{"name":"Program of Cardiovascular Diseases, CIMA University of Navarra and IdiSNA, Pamplona. Spain (C.B., S.R., B.L., M.U.M., J.D., A.G.)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Ibarrola","sequence":"additional","affiliation":[{"name":"From the Cardiovascular Translational Research, Navarrabiomed, Complejo Hospitalario de Navarra (CHN), Universidad P\u00fablica de Navarra (UPNA), IdiSNA, Pamplona. Spain (E.M.-M., J.I., A.F.-C., N.L.-A.)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Ravassa","sequence":"additional","affiliation":[{"name":"Program of Cardiovascular Diseases, CIMA University of Navarra and IdiSNA, Pamplona. Spain (C.B., S.R., B.L., M.U.M., J.D., A.G.)"},{"name":"CIBERCV, Carlos III Institute of Health, Madrid. Spain (S.R., B.L., M.U.M., J.D., A.G.)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Buonafine","sequence":"additional","affiliation":[{"name":"INSERM UMRS 1138 Team 1, Centre de Recherche des Cordeliers, University Pierre and Marie Curie, Paris, France (E.M.M., M.B., F.J.)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bego\u00f1a","family":"L\u00f3pez","sequence":"additional","affiliation":[{"name":"Program of Cardiovascular Diseases, CIMA University of Navarra and IdiSNA, Pamplona. Spain (C.B., S.R., B.L., M.U.M., J.D., A.G.)"},{"name":"CIBERCV, Carlos III Institute of Health, Madrid. Spain (S.R., B.L., M.U.M., J.D., A.G.)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amaya","family":"Fern\u00e1ndez-Celis","sequence":"additional","affiliation":[{"name":"From the Cardiovascular Translational Research, Navarrabiomed, Complejo Hospitalario de Navarra (CHN), Universidad P\u00fablica de Navarra (UPNA), IdiSNA, Pamplona. Spain (E.M.-M., J.I., A.F.-C., N.L.-A.)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ram\u00f3n","family":"Querejeta","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Donostia University Hospital, Biodonostia, Basque Country University, San Sebasti\u00e1n, Spain (R.Q.)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"Santamaria","sequence":"additional","affiliation":[{"name":"Proteored-ISCIII, Proteomics Unit, Navarrabiomed, Departamento de Salud, UPNA, IdiSNA, Pamplona, Spain (E.S., J.F.-I.)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaqu\u00edn","family":"Fern\u00e1ndez-Irigoyen","sequence":"additional","affiliation":[{"name":"Proteored-ISCIII, Proteomics Unit, Navarrabiomed, Departamento de Salud, UPNA, IdiSNA, Pamplona, Spain (E.S., J.F.-I.)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregorio","family":"R\u00e1bago","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Cardiac Surgery (G.R., J.D.), Clinic Universtity of Navarra, Pamplona. Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda U","family":"Moreno","sequence":"additional","affiliation":[{"name":"Program of Cardiovascular Diseases, CIMA University of Navarra and IdiSNA, Pamplona. Spain (C.B., S.R., B.L., M.U.M., J.D., A.G.)"},{"name":"CIBERCV, Carlos III Institute of Health, Madrid. Spain (S.R., B.L., M.U.M., J.D., A.G.)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Jaisser","sequence":"additional","affiliation":[{"name":"INSERM UMRS 1138 Team 1, Centre de Recherche des Cordeliers, University Pierre and Marie Curie, Paris, France (E.M.M., M.B., F.J.)"},{"name":"INSERM, Centre d\u2019Investigations Cliniques-Plurith\u00e9matique 1433, UMR 1116 Universit\u00e9 de Lorraine, CHRU de Nancy, France (F.J., N.L.-A.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"D\u00edez","sequence":"additional","affiliation":[{"name":"Program of Cardiovascular Diseases, CIMA University of Navarra and IdiSNA, Pamplona. Spain (C.B., S.R., B.L., M.U.M., J.D., A.G.)"},{"name":"CIBERCV, Carlos III Institute of Health, Madrid. Spain (S.R., B.L., M.U.M., J.D., A.G.)"},{"name":"Department of Cardiology and Cardiac Surgery (G.R., J.D.), Clinic Universtity of Navarra, Pamplona. Spain"},{"name":"Department of Nephrology (J.D.), Clinic Universtity of Navarra, Pamplona. Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arantxa","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[{"name":"Program of Cardiovascular Diseases, CIMA University of Navarra and IdiSNA, Pamplona. Spain (C.B., S.R., B.L., M.U.M., J.D., A.G.)"},{"name":"CIBERCV, Carlos III Institute of Health, Madrid. Spain (S.R., B.L., M.U.M., J.D., A.G.)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"L\u00f3pez-Andr\u00e9s","sequence":"additional","affiliation":[{"name":"From the Cardiovascular Translational Research, Navarrabiomed, Complejo Hospitalario de Navarra (CHN), Universidad P\u00fablica de Navarra (UPNA), IdiSNA, Pamplona. Spain (E.M.-M., J.I., A.F.-C., N.L.-A.)"},{"name":"INSERM, Centre d\u2019Investigations Cliniques-Plurith\u00e9matique 1433, UMR 1116 Universit\u00e9 de Lorraine, CHRU de Nancy, France (F.J., N.L.-A.)."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrcardio.2017.65"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI87491"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11897-014-0219-3"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.114.013215"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2010.10.024"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000140973.60992.9A"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000001258"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.112.201699"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.113.02654"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.hjh.0000184406.12634.f9"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e32831ac981"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.112.194407"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.5114\/aoms.2016.58664"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.696"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1042\/CS20170145"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.112.300569"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.116.004360"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000001545"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.246"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurjhf\/hfr151"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.115.05876"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00283.2011"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2014.08.002"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-12305-7"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2017-000461"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000001218"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e328337fe42"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1159\/000354499"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00096.2016"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1111\/1440-1681.12473"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1081\/CEH-57423"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.116.003804"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000147181.65298.4D"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2006.03.061"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.3109\/07853890.2010.538080"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.203"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejheart.2007.07.015"}],"container-title":["Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/HYPERTENSIONAHA.118.11874","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T10:23:54Z","timestamp":1715595834000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/HYPERTENSIONAHA.118.11874"}},"subtitle":["Mechanistic Insights and Clinical Implications"],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["10.1161\/HYPERTENSIONAHA.118.11874"],"URL":"https:\/\/doi.org\/10.1161\/hypertensionaha.118.11874","relation":{},"ISSN":["0194-911X","1524-4563"],"issn-type":[{"value":"0194-911X","type":"print"},{"value":"1524-4563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"2018-07-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-12-13","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-01-07","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}